Adjuvant endocrine therapy in patients with estrogen receptor-low positive breast cancer: A prospective cohort study

BACKGROUND: Little is known about the benefits of adjuvant endocrine therapy (ET) in low ER-positive breast cancer (1%–10%) patients. We analyzed the association between ET and breast cancer-specific survival (BCSS) in these patients with respect to the regimen and the duration of ET. METHODS: Patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Yuxin, Yang, Libo, Wu, Yanqi, Zheng, Hong, Gou, Qiheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551143/
https://www.ncbi.nlm.nih.gov/pubmed/36209701
http://dx.doi.org/10.1016/j.breast.2022.09.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551143/
https://www.ncbi.nlm.nih.gov/pubmed/36209701
http://dx.doi.org/10.1016/j.breast.2022.09.008

Ejemplares similares